[1] |
Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus[J]. Nat Rev Dis Primers, 2017,3:17026. doi: 10.1038/nrdp.2017. 26.
|
[2] |
Melchionda V, Harman KE. Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management[J]. Clin Exp Dermatol, 2019,44(7):740⁃746. doi: 10.1111/ced.14041.
|
[3] |
冯素英, 周武庆, 张洁尘, 等. 天疱疮患者桥粒芯糖蛋白抗体水平和疾病活动度关系及变化规律分析[J]. 中华皮肤科杂志, 2014,47(7):461⁃464. doi: 10.3760/cma.j.issn.0412⁃4030. 2014.07.003.
|
[4] |
Koopai M, Mortazavi H, Khatami A, et al. Salivary and serum anti⁃desmoglein 1 and 3 ELISA and indirect immunofluorescence in pemphigus vulgaris: correlations with serum ELISA, indirect immunofluorescence and disease severity[J]. Acta Dermatovenerol Croat, 2018,26(2):91⁃99.
|
[5] |
Russo I, De Siena FP, Saponeri A, et al. Evaluation of anti⁃desmoglein⁃1 and anti⁃desmoglein⁃3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission[J]. Medicine (Baltimore), 2017,96(46):e8801. doi: 10.1097/MD.0000000000008801.
|
[6] |
Patsatsi A, Kyriakou A, Giannakou A, et al. Clinical significance of anti⁃desmoglein⁃1 and ⁃3 circulating autoantibodies in pemphigus patients measured by area index and intensity score[J]. Acta Derm Venereol, 2014,94(2):203⁃206. doi: 10.2340/00015555⁃1666.
|
[7] |
Kamiya K, Aoyama Y, Shirafuji Y, et al. Detection of antibodies against the non⁃calcium⁃dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance[J]. Br J Dermatol, 2012,167(2):252⁃261. doi: 10.1111/j.1365⁃2133.2012. 10929.x.
|
[8] |
Kamiya K, Aoyama Y, Shirafuji Y, et al. A higher correlation of the antibody activities against the calcium⁃dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid⁃treated enzyme⁃linked immunosorbent assay with clinical disease activities of pemphigus vulgaris[J]. J Dermatol Sci, 2013,70(3):190⁃195. doi: 10.1016/j.jdermsci.2013.02.011.
|
[9] |
Lakshmi M, Jaisankar TJ, Rajappa M, et al. Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus[J]. J Am Acad Dermatol, 2017,76(5):895⁃902. doi: 10.1016/j.jaad.2016.11.039.
|
[10] |
Di Zenzo G, Di Lullo G, Corti D, et al. Pemphigus autoantibodies generated through somatic mutations target the desmoglein⁃3 cis⁃interface[J]. J Clin Invest, 2012,122(10):3781⁃3790. doi: 10. 1172/JCI64413.
|
[11] |
李志量, 张洁尘, 徐浩翔, 等. 胆碱能受体激动剂逆转天疱疮棘层松解的机制研究[J]. 中华皮肤科杂志, 2015,48(4):261⁃265. doi: 10.3760/cma.j.issn.0412⁃4030.2015.04.011.
|
[12] |
Chernyavsky A, Chen Y, Wang PH, et al. Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis[J]. Int Immunopharmacol, 2015,29(1):76⁃80. doi: 10.1016/j.intimp. 2015.04.046.
|
[13] |
Yeoh SC, Byth⁃Wilson K, Murrell DF, et al. Pemphigus vulgaris disease activity: the role of antibodies to desmogleins and their isotype[J]. J Oral Pathol Med, 2019,48(7):619⁃625. doi: 10. 1111/jop.12913.
|
[14] |
Dhandha MM, Seiffert⁃Sinha K, Sinha AA. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in pemphigus vulgaris[J]. Autoimmunity, 2012,45(7):516⁃526. doi: 10.3109/08916934. 2012.702811.
|